Biodesix, Inc.
BDSX
$0.50
-$0.049-8.93%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -42.93M | -43.82M | -44.51M | -47.06M | -52.15M |
| Total Depreciation and Amortization | 5.77M | 5.63M | 5.38M | 5.38M | 5.51M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.18M | 10.42M | 12.36M | 12.45M | 12.47M |
| Change in Net Operating Assets | -21.67M | -29.06M | -23.23M | -1.27M | 11.30M |
| Cash from Operations | -48.65M | -56.84M | -50.00M | -30.50M | -22.87M |
| Capital Expenditure | -3.23M | -5.38M | -10.99M | -15.48M | -22.92M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -210.00K | -182.00K | -168.00K | -152.00K | -143.00K |
| Cash from Investing | -3.44M | -5.56M | -11.15M | -15.63M | -23.06M |
| Total Debt Issued | -- | 10.00M | 10.00M | 10.00M | 10.00M |
| Total Debt Repaid | -51.00K | -51.00K | -50.00K | -50.00K | -49.00K |
| Issuance of Common Stock | 56.28M | 69.08M | 84.27M | 29.34M | 28.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.17M | -5.07M | -8.25M | -6.95M | -9.68M |
| Cash from Financing | 52.05M | 73.96M | 85.97M | 32.34M | 29.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -39.00K | 11.57M | 24.81M | -13.78M | -16.80M |